0.45% sodium chloride with 5% dextose (D5W) intravenous fluids
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 0.45% sodium chloride with 5% dextose (D5W) intravenous fluids, covering 2013-08-26 to 2013-08-26. Get the full timeline:
Most recent: Clinical Trial Update: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children [Phase 3]